Coronary and Valvular Heart Disease Research Groups
A list of the current PI-led Research Groups within the Coronary & Valvular Heart Disease research theme.
The Coronary & Valvular Heart Disease theme has several research groups that specialise in various topics within this theme.
| Name | Area of Expertise |
|---|---|
| Philip Adamson | Cardiology |
| Andy Baker | Vascular injury and repair, non-coding RNA, and advanced therapies |
| Cecile Benezech | Mature cell function, Inflammation, lymphoid tissue |
| Mairi Brittan | Cardiovascular regeneration |
| Andrea Caporali | Ischemic disease, vascular signalling during post-ischaemic angiogenesis and vascular repair |
| Karen Chapman | Glucocorticoids, developmental processes, in utero effects, metabolism of liver and heart |
| You Ying Chau | Adipose cell lineage and heterogeneity, visceral/subcutaneous adipose tissue |
| Mihaela Crisan | Pericytes, endothelial cell interaction |
| Fernando de la Cuesta | |
| Martin Denvir | Cardiology |
| Marc Dweck | Novel imaging of aortic stenosis, cardiomyopathy, and coronary atherosclerosis |
| Gillian Gray | Myocardial injury, inflammation in repair and remodelling, re-clinical models, non-invasive imaging, pharmacology and translation |
| Paddy Hadoke | Mechanisms that regulate arterial function; endothelium, new blood vessel formation, and lesion formation |
| Peter Henriksen | Cardiology, Cardiac CT/MRI |
| Maurits Jansen | Preclinical imaging |
| Mark Miller | Cardiovascular effects of air pollution, engineered nanoparticles |
| Nick Mills | Clinical cardiology, healthcare data, cardiac biomarkers and data-enabled clinical trials |
| James Minchin | Adipose cell biology, model organisms, genetics, In vivo imaging, CRISPR mutagenesis screens |
| Tijana Mitic | Epigenetics of vascular dysfunction in injury and hypoxia; Long non-coding RNAs (lncRNAs) targeting chromatin, their interaction with Polycomb and RNA binding proteins, Repurposing of PRC2 inhibitors for cardiovascular therapy |
| Carmel Moran | Ultrasound imaging, therapy and ultrasonic contrast agents |
| David Newby | Experimental medicine; advanced imaging of coronary heart disease, aortic stenosis, and heart failure |
| Bruno Peault | Vascular Regeneration |
| Sari Pennings | Epigenetics in development and environmental exposure; nuclear chromatin control of gene expression |
| Scott Semple | Non-invasive clinical imaging |
| Adriana Tavares | PET imaging, radiotracers |